Securing Reagent Supplies and Scaling COVID-19 [Funder: Genome BC, UBC]

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19
  • Funder

    Other Funders (Canada)
  • Principal Investigator

    Drs. Martin Hirst, Natalie Prystajecky, Mel Krajden, Marco Marra, Robin Coope, Gregg Morin, Rob Holt, Agatha Jassem, Thibault Mayor, Sheila Teves, Ivan Sadowski
  • Research Location

    Canada
  • Lead Research Institution

    University of British Columbia, BCCDC
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    N/A

  • Study Type

    Not applicable

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

As the COVID-19 pandemic expands around the world, the BC Centre for Disease Control and other testing sites are facing two dire problems: a shortage in reagents and the personnel needed to ramp-up diagnostic testing. In the immediate term the project team will ensure that BC can maintain and expand its capacity for COVID-19 testing by making sure that reagent sources can be sourced locally. In the medium term, these reagents will be further validated, and production scaled up to meet the accelerating testing demands in BC. The establishment of molecular resources, protocols and formulations will also ensure that BC and Canada are prepared to meet future pandemics in the face of disrupted global supply chains. Ultimately, a stable supply of reagents, produced locally, will allow expansion of testing to mild/asymptomatic cases, resulting in enhanced contact tracing and isolation that will limit onward transmission.